pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-133a-1 |
Genomic Coordinates | chr18: 21825698 - 21825785 |
Synonyms | MIRN133A1, MIR133A1 |
Description | Homo sapiens miR-133a-1 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-133a-2 |
Genomic Coordinates | chr20: 62564912 - 62565013 |
Synonyms | MIRN133A2, MIR133A2 |
Description | Homo sapiens miR-133a-2 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-133a-3p | |||||||||||||||||||||||||||
Sequence | 53| UUUGGUCCCCUUCAACCAGCUG |74 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KCNQ1 | ||||||||||||||||||||
Synonyms | ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, KVLQT1, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS | ||||||||||||||||||||
Description | potassium voltage-gated channel subfamily Q member 1 | ||||||||||||||||||||
Transcript | NM_000218 | ||||||||||||||||||||
Other Transcripts | NM_181798 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KCNQ1 | |||||||||||||||||||||
3'UTR of KCNQ1 (miRNA target sites are highlighted) |
>KCNQ1|NM_000218|3'UTR 1 GGAGGGGATGGGGCTGGGGGATGGGCCTGAGTGAGAGGGGAGGCCAAGAGTGGCCCCACCTGGCCCTCTCTGAAGGAGGC 81 CACCTCCTAAAAGGCCCAGAGAGAAGAGCCCCACTCTCAGAGGCCCCAATACCCCATGGACCATGCTGTCTGGCACAGCC 161 TGCACTTGGGGGCTCAGCAAGGCCACCTCTTCCTGGCCGGTGTGGGGGCCCCGTCTCAGGTCTGAGTTGTTACCCCAAGC 241 GCCCTGGCCCCCACATGGTGATGTTGACATCACTGGCATGGTGGTTGGGACCCAGTGGCAGGGCACAGGGCCTGGCCCAT 321 GTATGGCCAGGAAGTAGCACAGGCTGAGTGCAGGCCCACCCTGCTTGGCCCAGGGGGCTTCCTGAGGGGAGACAGAGCAA 401 CCCCTGGACCCCAGCCTCAAATCCAGGACCCTGCCAGGCACAGGCAGGGCAGGACCAGCCCACGCTGACTACAGGGCCGC 481 CGGCAATAAAAGCCCAGGAGCCCATTTGGAGGGCCTGGGCCTGGCTCCCTCACTCTCAGGAAATGCTGACCCATGGGCAG 561 GAGACTGTGGAGACTGCTCCTGAGCCCCCAGCTTCCAGCAGGAGGGACAGTCTCACCATTTCCCCAGGGCACGTGGTTGA 641 GTGGGGGGAACGCCCACTTCCCTGGGTTAGACTGCCAGCTCTTCCTAGCTGGAGAGGAGCCCTGCCTCTCCGCCCCTGAG 721 CCCACTGTGCGTGGGGCTCCCGCCTCCAACCCCTCGCCCAGTCCCAGCAGCCAGCCAAACACACAGAAGGGGACTGCCAC 801 CTCCCCTTGCCAGCTGCTGAGCCGCAGAGAAGTGACGGTTCCTACACAGGACAGGGGTTCCTTCTGGGCATTACATCGCA 881 TAGAAATCAATAATTTGTGGTGATTTGGATCTGTGTTTTAATGAGTTTCACAGTGTGATTTTGATTATTAATTGTGCAAG 961 CTTTTCCTAATAAACGTGGAGAATCACAGGCTGGGCTGGGCACTGCTCTCACCTTGGTTCCTGGGGCATCCATGGGGTCT 1041 CTCACAGACAGGACCCCTGCAGTTCCCCTGGAAGCAGTGCCCAGGTGGCTGTGGAATAGGAACGCTAAAAAAAAAAAAAA 1121 AAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
3' untranslated regions (3' UTRs) of the genes and experimentally established KCNQ1 and KCNE1 as targets for repression by muscle specifeid microRNAs miR-133 and miR-1
... - Luo X; Xiao J; Lin H; Li B; Lu Y; Yang B; Wang Z, 2007, Journal of cellular physiology. |
Article |
- Luo X; Xiao J; Lin H; Li B; Lu Y; Yang B; Wang Z - Journal of cellular physiology, 2007
In cardiac cells, KCNQ1 assembles with KCNE1 and forms a channel complex constituting the slow delayed rectifier current I(Ks). Expression of KCNQ1 and KCNE1 are regionally heterogeneous and changes with pathological states of the heart. The aims of this study were to decipher the molecular mechanisms for transcriptional and post-transcriptional regulation expression of KCNQ1 and KCNE1 genes and to shed light on the molecular mechanisms for their spatial heterogeneity of distribution. We cloned the 5'-flanking region and identified the transcription start sites of the KCNQ1 gene. We characterized the core promoters of KCNQ1 and KCNE1 and revealed the stimulating protein (Sp1) as a common transactivator of KCNQ1 and KCNE1 by interacting with the Sp1 cis-acting elements in the core promoter regions of these genes. We also characterized the 3' untranslated regions (3'UTRs) of the genes and experimentally established KCNQ1 and KCNE1 as targets for repression by the muscle-specific microRNAs miR-133 and miR-1, respectively. We demonstrated spatial heterogeneity of KCNQ1 and KCNE1 distributions at three axes (interventricular, transmural and apical-basal) and disparity between mRNA and protein expressions of these genes. We also found characteristic regional differences of expressions of Sp1 and miR-1/miR-133 in the heart. Our study unraveled a novel aspect of the cellular function of miRNAs and suggests that the I(Ks)-encoding genes KCNQ1 and KCNE1 expressions are dynamically balanced by transcription factor regulation and miRNA repression. The heterogeneities of Sp1 and miR-1/miR-133 offer an explanation for the well-recognized regional differences and disparity between mRNA and protein expressions of KCNQ1 and KCNE1.
LinkOut: [PMID: 17443681]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
122 hsa-miR-133a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT000325 | RHOA | ras homolog family member A | 1 | 2 | ||||||||
MIRT000327 | CDC42 | cell division cycle 42 | 4 | 2 | ||||||||
MIRT000328 | ERG | ERG, ETS transcription factor | 1 | 1 | ||||||||
MIRT000329 | HCN4 | hyperpolarization activated cyclic nucleotide gated potassium channel 4 | 2 | 1 | ||||||||
MIRT000330 | UCP2 | uncoupling protein 2 | 2 | 2 | ||||||||
MIRT000331 | KRT7 | keratin 7 | 2 | 2 | ||||||||
MIRT001203 | CACNA1C | calcium voltage-gated channel subunit alpha1 C | 3 | 1 | ||||||||
MIRT001204 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | 4 | 2 | ||||||||
MIRT001816 | PKM | pyruvate kinase, muscle | 1 | 1 | ||||||||
MIRT001986 | CASP9 | caspase 9 | 3 | 3 | ||||||||
MIRT002925 | KCNQ1 | potassium voltage-gated channel subfamily Q member 1 | 4 | 1 | ||||||||
MIRT003542 | FSCN1 | fascin actin-bundling protein 1 | 5 | 4 | ||||||||
MIRT004831 | KCNH2 | potassium voltage-gated channel subfamily H member 2 | 4 | 1 | ||||||||
MIRT005604 | TAGLN2 | transgelin 2 | 5 | 4 | ||||||||
MIRT005813 | LASP1 | LIM and SH3 protein 1 | 3 | 2 | ||||||||
MIRT006571 | PNP | purine nucleoside phosphorylase | 4 | 2 | ||||||||
MIRT006680 | MSN | moesin | 2 | 1 | ||||||||
MIRT007032 | EGFR | epidermal growth factor receptor | 3 | 5 | ||||||||
MIRT007088 | VKORC1 | vitamin K epoxide reductase complex subunit 1 | 1 | 1 | ||||||||
MIRT007383 | PRDM16 | PR/SET domain 16 | 1 | 2 | ||||||||
MIRT021693 | TPM1 | tropomyosin 1 | 1 | 1 | ||||||||
MIRT021695 | FBN1 | fibrillin 1 | 1 | 1 | ||||||||
MIRT021696 | FAM120C | family with sequence similarity 120C | 1 | 1 | ||||||||
MIRT021697 | BCAN | brevican | 1 | 1 | ||||||||
MIRT021698 | TCTEX1D2 | Tctex1 domain containing 2 | 1 | 1 | ||||||||
MIRT021699 | ARL6IP1 | ADP ribosylation factor like GTPase 6 interacting protein 1 | 1 | 1 | ||||||||
MIRT021700 | RFT1 | RFT1 homolog | 1 | 1 | ||||||||
MIRT021701 | SENP1 | SUMO1/sentrin specific peptidase 1 | 1 | 1 | ||||||||
MIRT021702 | SMIM14 | small integral membrane protein 14 | 1 | 1 | ||||||||
MIRT021703 | PRELID1 | PRELI domain containing 1 | 1 | 1 | ||||||||
MIRT021704 | CNN2 | calponin 2 | 3 | 3 | ||||||||
MIRT021705 | ARPC5 | actin related protein 2/3 complex subunit 5 | 4 | 2 | ||||||||
MIRT021706 | FTL | ferritin light chain | 2 | 2 | ||||||||
MIRT021707 | CERS2 | ceramide synthase 2 | 1 | 1 | ||||||||
MIRT021708 | SEC61B | Sec61 translocon beta subunit | 1 | 1 | ||||||||
MIRT021709 | PLEKHA3 | pleckstrin homology domain containing A3 | 1 | 1 | ||||||||
MIRT021710 | EGFL7 | EGF like domain multiple 7 | 1 | 1 | ||||||||
MIRT021711 | VEGFA | vascular endothelial growth factor A | 1 | 1 | ||||||||
MIRT021712 | PIK3R2 | phosphoinositide-3-kinase regulatory subunit 2 | 1 | 1 | ||||||||
MIRT021713 | RGS3 | regulator of G protein signaling 3 | 1 | 1 | ||||||||
MIRT021714 | COL1A1 | collagen type I alpha 1 chain | 4 | 1 | ||||||||
MIRT021715 | GSTP1 | glutathione S-transferase pi 1 | 2 | 1 | ||||||||
MIRT035537 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT035579 | KLF15 | Kruppel like factor 15 | 1 | 1 | ||||||||
MIRT045837 | NR4A2 | nuclear receptor subfamily 4 group A member 2 | 1 | 1 | ||||||||
MIRT052647 | BCL2L1 | BCL2 like 1 | 4 | 2 | ||||||||
MIRT052648 | MCL1 | MCL1, BCL2 family apoptosis regulator | 4 | 2 | ||||||||
MIRT053333 | RFFL | ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 4 | 1 | ||||||||
MIRT054310 | IGF1R | insulin like growth factor 1 receptor | 3 | 2 | ||||||||
MIRT055599 | FAM160B1 | family with sequence similarity 160 member B1 | 2 | 2 | ||||||||
MIRT081957 | UBA2 | ubiquitin like modifier activating enzyme 2 | 4 | 1 | ||||||||
MIRT437400 | MMP14 | matrix metallopeptidase 14 | 3 | 1 | ||||||||
MIRT437953 | ANXA2 | annexin A2 | 4 | 1 | ||||||||
MIRT437954 | SNX30 | sorting nexin family member 30 | 4 | 1 | ||||||||
MIRT437955 | SGMS2 | sphingomyelin synthase 2 | 4 | 1 | ||||||||
MIRT438719 | PDLIM5 | PDZ and LIM domain 5 | 3 | 1 | ||||||||
MIRT452802 | PACS2 | phosphofurin acidic cluster sorting protein 2 | 2 | 2 | ||||||||
MIRT462823 | BCL3 | B-cell CLL/lymphoma 3 | 2 | 2 | ||||||||
MIRT468494 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT477714 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT483852 | EMID1 | EMI domain containing 1 | 2 | 2 | ||||||||
MIRT490039 | PRRT2 | proline rich transmembrane protein 2 | 2 | 2 | ||||||||
MIRT491349 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 4 | ||||||||
MIRT504443 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT505701 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT513521 | RHOQ | ras homolog family member Q | 2 | 4 | ||||||||
MIRT517423 | HIST2H2AC | histone cluster 2 H2A family member c | 2 | 2 | ||||||||
MIRT526599 | DCAKD | dephospho-CoA kinase domain containing | 2 | 2 | ||||||||
MIRT528904 | THBS2 | thrombospondin 2 | 2 | 2 | ||||||||
MIRT533060 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT534126 | SNX33 | sorting nexin 33 | 2 | 2 | ||||||||
MIRT534700 | RNF103-CHMP3 | RNF103-CHMP3 readthrough | 2 | 4 | ||||||||
MIRT535732 | MYPN | myopalladin | 2 | 2 | ||||||||
MIRT538529 | CHMP3 | charged multivesicular body protein 3 | 2 | 4 | ||||||||
MIRT550878 | IBA57 | IBA57 homolog, iron-sulfur cluster assembly | 2 | 2 | ||||||||
MIRT551260 | PSMG1 | proteasome assembly chaperone 1 | 2 | 2 | ||||||||
MIRT551981 | UGT2B10 | UDP glucuronosyltransferase family 2 member B10 | 2 | 2 | ||||||||
MIRT553866 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT558810 | CDK5R1 | cyclin dependent kinase 5 regulatory subunit 1 | 2 | 2 | ||||||||
MIRT559367 | ATP13A3 | ATPase 13A3 | 2 | 2 | ||||||||
MIRT560941 | ZFP28 | ZFP28 zinc finger protein | 2 | 2 | ||||||||
MIRT565461 | SUPT16H | SPT16 homolog, facilitates chromatin remodeling subunit | 2 | 2 | ||||||||
MIRT566234 | PTMA | prothymosin, alpha | 2 | 2 | ||||||||
MIRT568217 | C11orf24 | chromosome 11 open reading frame 24 | 2 | 2 | ||||||||
MIRT608912 | NCDN | neurochondrin | 2 | 6 | ||||||||
MIRT613229 | CCDC39 | coiled-coil domain containing 39 | 2 | 2 | ||||||||
MIRT623563 | ITPKB | inositol-trisphosphate 3-kinase B | 2 | 2 | ||||||||
MIRT637224 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT641669 | CCNI | cyclin I | 2 | 2 | ||||||||
MIRT644440 | ALDOC | aldolase, fructose-bisphosphate C | 2 | 2 | ||||||||
MIRT644755 | TXNRD3NB | thioredoxin reductase 3 neighbor | 2 | 2 | ||||||||
MIRT646711 | PDE1A | phosphodiesterase 1A | 2 | 2 | ||||||||
MIRT647577 | RBMXL1 | RNA binding motif protein, X-linked like 1 | 2 | 2 | ||||||||
MIRT647760 | RNF168 | ring finger protein 168 | 2 | 2 | ||||||||
MIRT649267 | C17orf64 | chromosome 17 open reading frame 64 | 2 | 2 | ||||||||
MIRT651238 | ZMAT4 | zinc finger matrin-type 4 | 2 | 2 | ||||||||
MIRT652146 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT657168 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT668302 | FOSL2 | FOS like 2, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT687546 | MLEC | malectin | 2 | 2 | ||||||||
MIRT690857 | PLEKHG2 | pleckstrin homology and RhoGEF domain containing G2 | 2 | 2 | ||||||||
MIRT697060 | PSMC4 | proteasome 26S subunit, ATPase 4 | 2 | 2 | ||||||||
MIRT699725 | SERPINH1 | serpin family H member 1 | 2 | 2 | ||||||||
MIRT700858 | PER2 | period circadian clock 2 | 2 | 2 | ||||||||
MIRT705068 | C4orf29 | abhydrolase domain containing 18 | 2 | 2 | ||||||||
MIRT709496 | ANGPT4 | angiopoietin 4 | 2 | 2 | ||||||||
MIRT713925 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT716058 | SFTPB | surfactant protein B | 2 | 2 | ||||||||
MIRT716724 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT721677 | CMTM4 | CKLF like MARVEL transmembrane domain containing 4 | 2 | 2 | ||||||||
MIRT723379 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 2 | ||||||||
MIRT731340 | IGF1 | insulin like growth factor 1 | 1 | 1 | ||||||||
MIRT731591 | ZEB1 | zinc finger E-box binding homeobox 1 | 1 | 1 | ||||||||
MIRT732526 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 0 | ||||||||
MIRT732527 | KDM5C | lysine demethylase 5C | 2 | 0 | ||||||||
MIRT732589 | BCL2 | BCL2, apoptosis regulator | 2 | 0 | ||||||||
MIRT732590 | CASP3 | caspase 3 | 2 | 0 | ||||||||
MIRT733594 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 3 | 0 | ||||||||
MIRT735355 | MB | myoglobin | 1 | 0 | ||||||||
MIRT735744 | CDCA8 | cell division cycle associated 8 | 3 | 0 | ||||||||
MIRT736984 | SET | SET nuclear proto-oncogene | 1 | 0 | ||||||||
MIRT737550 | TGFB1 | transforming growth factor beta 1 | 4 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|